Anti-inflammatory drugs are often the first step in the treatment of ulcerative colitis. They include: 5-aminosalicylates. Examples of this type of medication includesulfasalazine (Azulfidine), mesalamine (Asacol HD, Delzicol, others), balsalazide (Colazal) and olsalazine (Dipentum).
The global Ulcerative Colitis market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Ulcerative Colitis volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ulcerative Colitis market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Ulcerative Colitis in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Ulcerative Colitis manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Johnson & Johnson.
AbbVie
Takeda Pharmaceuticals
Roche
Warner Chilcott
Salix Pharmaceuticals/Santarus
Shire Pharmaceuticals
Ferring Pharmaceuticals
Pfizer
InDeX Pharmaceuticals
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Oral
Injection
Segment by Application
Hospital
Drugs Stores
The global Ulcerative Colitis market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Ulcerative Colitis volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ulcerative Colitis market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Ulcerative Colitis in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Ulcerative Colitis manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Johnson & Johnson.
AbbVie
Takeda Pharmaceuticals
Roche
Warner Chilcott
Salix Pharmaceuticals/Santarus
Shire Pharmaceuticals
Ferring Pharmaceuticals
Pfizer
InDeX Pharmaceuticals
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Oral
Injection
Segment by Application
Hospital
Drugs Stores
Table of Contents
Executive Summary
1 Industry Overview of Ulcerative Colitis
1.1 Definition of Ulcerative Colitis
1.2 Ulcerative Colitis Segment by Type
1.2.1 Global Ulcerative Colitis Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Oral
1.2.3 Injection
1.3 Ulcerative Colitis Segment by Applications
1.3.1 Global Ulcerative Colitis Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Drugs Stores
1.4 Global Ulcerative Colitis Overall Market
1.4.1 Global Ulcerative Colitis Revenue (2014-2025)
1.4.2 Global Ulcerative Colitis Production (2014-2025)
1.4.3 North America Ulcerative Colitis Status and Prospect (2014-2025)
1.4.4 Europe Ulcerative Colitis Status and Prospect (2014-2025)
1.4.5 China Ulcerative Colitis Status and Prospect (2014-2025)
1.4.6 Japan Ulcerative Colitis Status and Prospect (2014-2025)
1.4.7 Southeast Asia Ulcerative Colitis Status and Prospect (2014-2025)
1.4.8 India Ulcerative Colitis Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Ulcerative Colitis
2.3 Manufacturing Process Analysis of Ulcerative Colitis
2.4 Industry Chain Structure of Ulcerative Colitis
3 Development and Manufacturing Plants Analysis of Ulcerative Colitis
3.1 Capacity and Commercial Production Date
3.2 Global Ulcerative Colitis Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Ulcerative Colitis
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Ulcerative Colitis Production and Capacity Analysis
4.2 Ulcerative Colitis Revenue Analysis
4.3 Ulcerative Colitis Price Analysis
4.4 Market Concentration Degree
5 Ulcerative Colitis Regional Market Analysis
5.1 Ulcerative Colitis Production by Regions
5.1.1 Global Ulcerative Colitis Production by Regions
5.1.2 Global Ulcerative Colitis Revenue by Regions
5.2 Ulcerative Colitis Consumption by Regions
5.3 North America Ulcerative Colitis Market Analysis
5.3.1 North America Ulcerative Colitis Production
5.3.2 North America Ulcerative Colitis Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Ulcerative Colitis Import and Export
5.4 Europe Ulcerative Colitis Market Analysis
5.4.1 Europe Ulcerative Colitis Production
5.4.2 Europe Ulcerative Colitis Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Ulcerative Colitis Import and Export
5.5 China Ulcerative Colitis Market Analysis
5.5.1 China Ulcerative Colitis Production
5.5.2 China Ulcerative Colitis Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Ulcerative Colitis Import and Export
5.6 Japan Ulcerative Colitis Market Analysis
5.6.1 Japan Ulcerative Colitis Production
5.6.2 Japan Ulcerative Colitis Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Ulcerative Colitis Import and Export
5.7 Southeast Asia Ulcerative Colitis Market Analysis
5.7.1 Southeast Asia Ulcerative Colitis Production
5.7.2 Southeast Asia Ulcerative Colitis Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Ulcerative Colitis Import and Export
5.8 India Ulcerative Colitis Market Analysis
5.8.1 India Ulcerative Colitis Production
5.8.2 India Ulcerative Colitis Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Ulcerative Colitis Import and Export
6 Ulcerative Colitis Segment Market Analysis (by Type)
6.1 Global Ulcerative Colitis Production by Type
6.2 Global Ulcerative Colitis Revenue by Type
6.3 Ulcerative Colitis Price by Type
7 Ulcerative Colitis Segment Market Analysis (by Application)
7.1 Global Ulcerative Colitis Consumption by Application
7.2 Global Ulcerative Colitis Consumption Market Share by Application (2014-2019)
8 Ulcerative Colitis Major Manufacturers Analysis
8.1 Johnson & Johnson.
8.1.1 Johnson & Johnson. Ulcerative Colitis Production Sites and Area Served
8.1.2 Johnson & Johnson. Product Introduction, Application and Specification
8.1.3 Johnson & Johnson. Ulcerative Colitis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 AbbVie
8.2.1 AbbVie Ulcerative Colitis Production Sites and Area Served
8.2.2 AbbVie Product Introduction, Application and Specification
8.2.3 AbbVie Ulcerative Colitis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Takeda Pharmaceuticals
8.3.1 Takeda Pharmaceuticals Ulcerative Colitis Production Sites and Area Served
8.3.2 Takeda Pharmaceuticals Product Introduction, Application and Specification
8.3.3 Takeda Pharmaceuticals Ulcerative Colitis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Roche
8.4.1 Roche Ulcerative Colitis Production Sites and Area Served
8.4.2 Roche Product Introduction, Application and Specification
8.4.3 Roche Ulcerative Colitis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Warner Chilcott
8.5.1 Warner Chilcott Ulcerative Colitis Production Sites and Area Served
8.5.2 Warner Chilcott Product Introduction, Application and Specification
8.5.3 Warner Chilcott Ulcerative Colitis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Salix Pharmaceuticals/Santarus
8.6.1 Salix Pharmaceuticals/Santarus Ulcerative Colitis Production Sites and Area Served
8.6.2 Salix Pharmaceuticals/Santarus Product Introduction, Application and Specification
8.6.3 Salix Pharmaceuticals/Santarus Ulcerative Colitis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Shire Pharmaceuticals
8.7.1 Shire Pharmaceuticals Ulcerative Colitis Production Sites and Area Served
8.7.2 Shire Pharmaceuticals Product Introduction, Application and Specification
8.7.3 Shire Pharmaceuticals Ulcerative Colitis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Ferring Pharmaceuticals
8.8.1 Ferring Pharmaceuticals Ulcerative Colitis Production Sites and Area Served
8.8.2 Ferring Pharmaceuticals Product Introduction, Application and Specification
8.8.3 Ferring Pharmaceuticals Ulcerative Colitis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Pfizer
8.9.1 Pfizer Ulcerative Colitis Production Sites and Area Served
8.9.2 Pfizer Product Introduction, Application and Specification
8.9.3 Pfizer Ulcerative Colitis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 InDeX Pharmaceuticals
8.10.1 InDeX Pharmaceuticals Ulcerative Colitis Production Sites and Area Served
8.10.2 InDeX Pharmaceuticals Product Introduction, Application and Specification
8.10.3 InDeX Pharmaceuticals Ulcerative Colitis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Ulcerative Colitis Market
9.1 Global Ulcerative Colitis Market Trend Analysis
9.1.1 Global Ulcerative Colitis Market Size (Volume and Value) Forecast 2019-2025
9.2 Ulcerative Colitis Regional Market Trend
9.2.1 North America Ulcerative Colitis Forecast 2019-2025
9.2.2 Europe Ulcerative Colitis Forecast 2019-2025
9.2.3 China Ulcerative Colitis Forecast 2019-2025
9.2.4 Japan Ulcerative Colitis Forecast 2019-2025
9.2.5 Southeast Asia Ulcerative Colitis Forecast 2019-2025
9.2.6 India Ulcerative Colitis Forecast 2019-2025
9.3 Ulcerative Colitis Market Trend (Product Type)
9.4 Ulcerative Colitis Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Ulcerative Colitis Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Executive Summary
1 Industry Overview of Ulcerative Colitis
1.1 Definition of Ulcerative Colitis
1.2 Ulcerative Colitis Segment by Type
1.2.1 Global Ulcerative Colitis Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Oral
1.2.3 Injection
1.3 Ulcerative Colitis Segment by Applications
1.3.1 Global Ulcerative Colitis Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Drugs Stores
1.4 Global Ulcerative Colitis Overall Market
1.4.1 Global Ulcerative Colitis Revenue (2014-2025)
1.4.2 Global Ulcerative Colitis Production (2014-2025)
1.4.3 North America Ulcerative Colitis Status and Prospect (2014-2025)
1.4.4 Europe Ulcerative Colitis Status and Prospect (2014-2025)
1.4.5 China Ulcerative Colitis Status and Prospect (2014-2025)
1.4.6 Japan Ulcerative Colitis Status and Prospect (2014-2025)
1.4.7 Southeast Asia Ulcerative Colitis Status and Prospect (2014-2025)
1.4.8 India Ulcerative Colitis Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Ulcerative Colitis
2.3 Manufacturing Process Analysis of Ulcerative Colitis
2.4 Industry Chain Structure of Ulcerative Colitis
3 Development and Manufacturing Plants Analysis of Ulcerative Colitis
3.1 Capacity and Commercial Production Date
3.2 Global Ulcerative Colitis Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Ulcerative Colitis
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Ulcerative Colitis Production and Capacity Analysis
4.2 Ulcerative Colitis Revenue Analysis
4.3 Ulcerative Colitis Price Analysis
4.4 Market Concentration Degree
5 Ulcerative Colitis Regional Market Analysis
5.1 Ulcerative Colitis Production by Regions
5.1.1 Global Ulcerative Colitis Production by Regions
5.1.2 Global Ulcerative Colitis Revenue by Regions
5.2 Ulcerative Colitis Consumption by Regions
5.3 North America Ulcerative Colitis Market Analysis
5.3.1 North America Ulcerative Colitis Production
5.3.2 North America Ulcerative Colitis Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Ulcerative Colitis Import and Export
5.4 Europe Ulcerative Colitis Market Analysis
5.4.1 Europe Ulcerative Colitis Production
5.4.2 Europe Ulcerative Colitis Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Ulcerative Colitis Import and Export
5.5 China Ulcerative Colitis Market Analysis
5.5.1 China Ulcerative Colitis Production
5.5.2 China Ulcerative Colitis Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Ulcerative Colitis Import and Export
5.6 Japan Ulcerative Colitis Market Analysis
5.6.1 Japan Ulcerative Colitis Production
5.6.2 Japan Ulcerative Colitis Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Ulcerative Colitis Import and Export
5.7 Southeast Asia Ulcerative Colitis Market Analysis
5.7.1 Southeast Asia Ulcerative Colitis Production
5.7.2 Southeast Asia Ulcerative Colitis Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Ulcerative Colitis Import and Export
5.8 India Ulcerative Colitis Market Analysis
5.8.1 India Ulcerative Colitis Production
5.8.2 India Ulcerative Colitis Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Ulcerative Colitis Import and Export
6 Ulcerative Colitis Segment Market Analysis (by Type)
6.1 Global Ulcerative Colitis Production by Type
6.2 Global Ulcerative Colitis Revenue by Type
6.3 Ulcerative Colitis Price by Type
7 Ulcerative Colitis Segment Market Analysis (by Application)
7.1 Global Ulcerative Colitis Consumption by Application
7.2 Global Ulcerative Colitis Consumption Market Share by Application (2014-2019)
8 Ulcerative Colitis Major Manufacturers Analysis
8.1 Johnson & Johnson.
8.1.1 Johnson & Johnson. Ulcerative Colitis Production Sites and Area Served
8.1.2 Johnson & Johnson. Product Introduction, Application and Specification
8.1.3 Johnson & Johnson. Ulcerative Colitis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 AbbVie
8.2.1 AbbVie Ulcerative Colitis Production Sites and Area Served
8.2.2 AbbVie Product Introduction, Application and Specification
8.2.3 AbbVie Ulcerative Colitis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Takeda Pharmaceuticals
8.3.1 Takeda Pharmaceuticals Ulcerative Colitis Production Sites and Area Served
8.3.2 Takeda Pharmaceuticals Product Introduction, Application and Specification
8.3.3 Takeda Pharmaceuticals Ulcerative Colitis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Roche
8.4.1 Roche Ulcerative Colitis Production Sites and Area Served
8.4.2 Roche Product Introduction, Application and Specification
8.4.3 Roche Ulcerative Colitis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Warner Chilcott
8.5.1 Warner Chilcott Ulcerative Colitis Production Sites and Area Served
8.5.2 Warner Chilcott Product Introduction, Application and Specification
8.5.3 Warner Chilcott Ulcerative Colitis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Salix Pharmaceuticals/Santarus
8.6.1 Salix Pharmaceuticals/Santarus Ulcerative Colitis Production Sites and Area Served
8.6.2 Salix Pharmaceuticals/Santarus Product Introduction, Application and Specification
8.6.3 Salix Pharmaceuticals/Santarus Ulcerative Colitis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Shire Pharmaceuticals
8.7.1 Shire Pharmaceuticals Ulcerative Colitis Production Sites and Area Served
8.7.2 Shire Pharmaceuticals Product Introduction, Application and Specification
8.7.3 Shire Pharmaceuticals Ulcerative Colitis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Ferring Pharmaceuticals
8.8.1 Ferring Pharmaceuticals Ulcerative Colitis Production Sites and Area Served
8.8.2 Ferring Pharmaceuticals Product Introduction, Application and Specification
8.8.3 Ferring Pharmaceuticals Ulcerative Colitis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Pfizer
8.9.1 Pfizer Ulcerative Colitis Production Sites and Area Served
8.9.2 Pfizer Product Introduction, Application and Specification
8.9.3 Pfizer Ulcerative Colitis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 InDeX Pharmaceuticals
8.10.1 InDeX Pharmaceuticals Ulcerative Colitis Production Sites and Area Served
8.10.2 InDeX Pharmaceuticals Product Introduction, Application and Specification
8.10.3 InDeX Pharmaceuticals Ulcerative Colitis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Ulcerative Colitis Market
9.1 Global Ulcerative Colitis Market Trend Analysis
9.1.1 Global Ulcerative Colitis Market Size (Volume and Value) Forecast 2019-2025
9.2 Ulcerative Colitis Regional Market Trend
9.2.1 North America Ulcerative Colitis Forecast 2019-2025
9.2.2 Europe Ulcerative Colitis Forecast 2019-2025
9.2.3 China Ulcerative Colitis Forecast 2019-2025
9.2.4 Japan Ulcerative Colitis Forecast 2019-2025
9.2.5 Southeast Asia Ulcerative Colitis Forecast 2019-2025
9.2.6 India Ulcerative Colitis Forecast 2019-2025
9.3 Ulcerative Colitis Market Trend (Product Type)
9.4 Ulcerative Colitis Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Ulcerative Colitis Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
